Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Influenza vaccines: new developments.

G F Rimmelzwaan1, A D Osterhaust

  • 1Institute of Virology, National Influenza Center, Erasmus University Rotterdam, The Netherlands. rimmelzwaan@viro.fgg.eur.nl

Current Opinion in Pharmacology
|January 5, 2002
PubMed
Summary

Current influenza vaccines offer protection but new methods are needed for higher efficacy and faster production. Innovations include novel production technologies, reverse genetics, and adjuvants to improve vaccine performance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Factors associated with long-term antibody response after COVID-19 vaccination in patients treated with systemic treatment for solid tumors.

ESMO open·2023
Same author

One-year data on immunogenicity and breakthrough infections in patients with solid tumors vaccinated against COVID-19 during systemic cancer treatment.

ESMO open·2023
Same author

[Influenza vaccination of patients with solid tumours during chemotherapy: efficacy and safety].

Nederlands tijdschrift voor geneeskunde·2017
Same author

Protein and modified vaccinia virus Ankara-based influenza virus nucleoprotein vaccines are differentially immunogenic in BALB/c mice.

Clinical and experimental immunology·2017
Same author

A compensatory mutagenesis study of a conserved hairpin in the M gene segment of influenza A virus shows its role in virus replication.

RNA biology·2017
Same author

Microarray profile of the humoral immune response to influenza vaccination in breast cancer patients treated with chemotherapy.

Vaccine·2017

Area of Science:

  • * Virology and Immunology
  • * Vaccine Development and Production

Background:

  • * Current inactivated influenza vaccines rely on annual World Health Organization strain recommendations.
  • * Antigens are typically produced in embryonated chicken eggs, a method with limitations.
  • * Existing vaccines reduce influenza-related illness and death but have room for improvement.

Purpose of the Study:

  • * To explore advancements in influenza vaccine production for enhanced efficacy.
  • * To address the need for more rapid and flexible vaccine manufacturing.
  • * To investigate novel approaches for responding to influenza epidemics and pandemics.

Main Methods:

  • * Review of current influenza vaccine production using inactivated virus strains.
  • * Exploration of novel vaccine production technologies.

Related Experiment Videos

  • * Application of reverse genetics for vaccine strain generation.
  • * Investigation of novel adjuvants to boost immunogenicity.

    • Main Results:

    • * New developments offer potential for improved influenza vaccine efficacy.
    • * Novel technologies promise faster and more flexible vaccine production.
    • * Reverse genetics enables efficient generation of vaccine strains.
    • * Adjuvants can significantly enhance vaccine immunogenicity.

    Conclusions:

    • * Advancements in vaccine technology are crucial for combating influenza.
    • * Novel production methods and adjuvants are key to developing superior influenza vaccines.
    • * Future vaccines may offer better protection and quicker deployment during outbreaks.